KR850002972A - 퀴나졸린 유도체의 제조방법 - Google Patents

퀴나졸린 유도체의 제조방법 Download PDF

Info

Publication number
KR850002972A
KR850002972A KR1019840006046A KR840006046A KR850002972A KR 850002972 A KR850002972 A KR 850002972A KR 1019840006046 A KR1019840006046 A KR 1019840006046A KR 840006046 A KR840006046 A KR 840006046A KR 850002972 A KR850002972 A KR 850002972A
Authority
KR
South Korea
Prior art keywords
compound
formula
preparing
reacted
quinazoline derivatives
Prior art date
Application number
KR1019840006046A
Other languages
English (en)
Inventor
쉭카네더 헬무트 (외 3)
Original Assignee
푸르트 레닝 아렌스,레인홀트 포트만
루드비히 호이만 운트 코. 게엠바하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 푸르트 레닝 아렌스,레인홀트 포트만, 루드비히 호이만 운트 코. 게엠바하 filed Critical 푸르트 레닝 아렌스,레인홀트 포트만
Publication of KR850002972A publication Critical patent/KR850002972A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

내용 없음

Description

퀴나졸린 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 구조식(Ⅱ)의 화합물을 구조식(Ⅲ)의 N-시아노디페닐 이미도카보네이트와 반응시켜 R이인 구조식(Ⅰa) 화하물을 제조하거나, 이 구조식(Ⅰa)의 화합물을 알콜성 용매중에서 하이드라진하이드레이트나 머캅토 초산에스테르와 반응시켜 R이 1,2,4-트리아졸이나 1,3-타아졸인 구조식(Ⅰ) 화합물을 제조하고 임의로 그 약리학적으로 사용가능한 염으로 전시환킴을 특징으로 하는 구조식(Ⅰ)화합물 및 그 약리학적으로 사용가능한 염을 제조하는 방법.
    상기식에서, R은 트리아졸류, 옥사디아졸류, 티아졸류 및 이미다졸류로 이루어진 그룹에서 선택된 모노-트리치환 5-원-복소환이며, 이 복소환은 탄소원자에 의하여 피페라진 또는 호모피페라진환에 결합되어 있으며, n은 2 또는 3이거나, 또는 R은 N-시아노페닐이미도카보네이트기이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840006046A 1983-10-06 1984-09-29 퀴나졸린 유도체의 제조방법 KR850002972A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3336409.5 1983-10-06
DE3336409A DE3336409A1 (de) 1983-10-06 1983-10-06 Chinazolinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
KR850002972A true KR850002972A (ko) 1985-05-28

Family

ID=6211184

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840006046A KR850002972A (ko) 1983-10-06 1984-09-29 퀴나졸린 유도체의 제조방법

Country Status (14)

Country Link
US (1) US4578389A (ko)
EP (1) EP0139993A3 (ko)
JP (1) JPS6094972A (ko)
KR (1) KR850002972A (ko)
AU (1) AU3245784A (ko)
DE (1) DE3336409A1 (ko)
DK (1) DK451684A (ko)
ES (1) ES536306A0 (ko)
GR (1) GR80474B (ko)
HU (1) HUT35671A (ko)
IL (1) IL72781A0 (ko)
PT (1) PT79289A (ko)
YU (1) YU168284A (ko)
ZA (1) ZA846739B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0146642B1 (de) * 1983-11-22 1988-01-20 LUDWIG HEUMANN & CO GMBH Verfahren zur Herstellung von 4-Amino-6,7-dimethoxy-2-(4-(furo-2-yl)-piperazin-1-yl)-chinazolin und dessen physiologisch annehmbarer Salze
JPS6267077A (ja) * 1985-09-18 1987-03-26 Mitsui Petrochem Ind Ltd キナゾリン誘導体及び医薬
JPH0647540B2 (ja) * 1985-07-16 1994-06-22 エーザイ株式会社 虚血性心疾患・不整脈治療・予防剤
AT384218B (de) * 1985-12-04 1987-10-12 Gerot Pharmazeutika Verfahren zur herstellung von neuen chinazolin-derivaten
US4868182A (en) * 1986-11-05 1989-09-19 Merrell Dow Pharmaceuticals Inc. Enhancement of prazosin
FR2665161B1 (fr) * 1990-07-26 1992-11-27 Esteve Labor Dr Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.
FR2674856B1 (fr) * 1991-04-05 1993-07-30 Esteve Labor Dr Nouveaux antihistaminiques non sedatifs, derives de benzimidazole, leur procede de preparation et leur utilisation en tant que medicaments.
IT1286302B1 (it) * 1996-04-10 1998-07-08 Rotta Research Lab Chinazoline-4-amino-2-(piperidino-1-il-4-sostituite) ad attivita' anti-ipertensiva, procedimento per la loro preparazione e loro uso

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138561A (en) * 1977-09-30 1979-02-06 Bristol-Myers Company Cyanocarboxamidines and quinazoline process
US4377581A (en) * 1980-03-03 1983-03-22 Pfizer Inc. Chloro- and alkoxy-substituted-2,4-diaminoquinazolines
US4351832A (en) * 1980-04-18 1982-09-28 American Home Products Corporation 2-(Piperazinyl)-4-pyrimidinamines

Also Published As

Publication number Publication date
GR80474B (en) 1985-02-07
ES8506005A1 (es) 1985-07-01
DK451684A (da) 1985-04-07
EP0139993A2 (de) 1985-05-08
DE3336409A1 (de) 1985-04-18
ES536306A0 (es) 1985-07-01
IL72781A0 (en) 1984-11-30
PT79289A (de) 1984-11-01
EP0139993A3 (de) 1988-02-17
ZA846739B (en) 1985-04-24
JPS6094972A (ja) 1985-05-28
DK451684D0 (da) 1984-09-21
AU3245784A (en) 1985-04-18
US4578389A (en) 1986-03-25
YU168284A (en) 1986-12-31
HUT35671A (en) 1985-07-29

Similar Documents

Publication Publication Date Title
KR890006599A (ko) 복소환 유도체, 그의 제법 및 이를 활성성분으로 함유하는 방사선 감응제 및 항비루스제
KR840008016A (ko) 융합 이미다졸 화합물의 제조방법
KR850001171A (ko) 퀴놀린 화합물의 제조방법
KR830004309A (ko) β-락타마제 억제제로써의 6β-하이드록시 알킬 페니실란산 유도체
CA2009925A1 (en) Method for enhancement of chemiluminescence
KR850002972A (ko) 퀴나졸린 유도체의 제조방법
KR860008210A (ko) 글리코펩타이드 유도체의 제조 방법
KR840002816A (ko) 이미다졸 또는 트리아졸 유도체, 이들의 산부가염 및 이들의 금속착염의 제조방법
KR840008342A (ko) 모르포린 유도체의 제조방법
KR840006482A (ko) 디히드로피라졸로 [3,4-b]피리딘 유도체의 제조방법
KR860003259A (ko) 벤젠-융합 복소환 화합물의 제조방법
KR830004217A (ko) 약학적 활성이 있는 펩타이드
KR850008159A (ko) 2-페닐-4,5,6,7-테트라히드로-2h-인다졸류의 제조방법
KR830006209A (ko) 페닐프로 파르길아민 유도체의 제조방법
KR840006238A (ko) 신규 α-아릴-α-피리딜알카노인산 유도체의 제조방법
KR860002474A (ko) 치환된 페닐술포닐아졸의 제조방법
CA2040674A1 (en) Water-soluble methine compound and photographic silver halide emulsion containing the same
KR830009076A (ko) 3,5-디-3급-부틸-4-하이드록시페닐-치환 복소환 화합물의 제조방법
KR840002821A (ko) N-(2,3-에폭시프로필렌)-n-아르알킬술폰아미드 유도체의 제조방법
KR850003889A (ko) 복소환식 화합물
KR840000496A (ko) 요소유도체 및 그 제조방법
KR830001899A (ko) 4-아미노-3-퀴놀린카복실산 및 에스테르-항분비, 항궤양 화합물
KR840005721A (ko) 치환된 1,3,4-벤조트리아제핀의 제조방법
EP0329491A3 (en) Photographic elements incorporating antihalation and/or acutance dyes
KR860003230A (ko) 피라졸 유도체의 제조 방법

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid